Related Experiment Video
Updated: Jun 26, 2026

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model
Published on: September 3, 2020
Hemorrhagic Myocardial Infarction and Intramyocardial Hemorrhage: From Microvascular Damage to Emerging Therapeutic
Valentin Chioncel1,2, Anamaria-Georgiana Avram2, Raluca Ciomag1,2
1Department of Cardiology, University of Medicine and Pharmacy Carol Davila, 050474 Bucharest, Romania.
Insights
Intramyocardial hemorrhage (IMH) is a severe microvascular injury after heart attack, linked to worse outcomes. Cardiovascular magnetic resonance imaging can detect IMH, aiding risk stratification and potentially guiding future therapies for better patient recovery.
Area of Science:
- Cardiology
- Radiology
- Pathophysiology
Background:
- Intramyocardial hemorrhage (IMH) is a critical microvascular injury post-myocardial infarction (MI).
- IMH correlates with microvascular obstruction, larger infarcts, impaired left-ventricular function, and adverse clinical outcomes.
- Current evidence is largely observational, lacking prospective validation for IMH-guided management.
Purpose of the Study:
- To review the pathophysiology, diagnostic imaging, prognostic implications, and therapeutic potential of IMH.
- To highlight current knowledge gaps in standardized imaging and clinical implementation.
- To discuss future directions for phenotype-directed therapies for IMH.
Main Methods:
- This is a narrative review synthesizing existing research.
- Focus on cardiovascular magnetic resonance (CMR) techniques, particularly T2* and R2* mapping.
- Analysis of mechanistic, translational, and clinical studies on IMH.
Main Results:
- IMH is associated with adverse cardiac remodeling and poor clinical outcomes.
- Susceptibility-sensitive CMR techniques enable in vivo detection of IMH.
- Iron deposition from erythrocyte degradation may drive persistent inflammation and adverse healing.
Conclusions:
- IMH is a significant marker of severe post-MI injury with prognostic implications.
- CMR offers a valuable tool for diagnosing IMH and refining risk stratification.
- Further research is needed for standardized imaging protocols and prospective validation of IMH-guided therapies.
Abstract:
Intramyocardial hemorrhage (IMH) is a severe form of post-ischemic microvascular injury that may occur after myocardial infarction, particularly in the setting of extensive ischemia and reperfusion. IMH is closely related to microvascular obstruction (MVO), larger infarct size, impaired left-ventricular (LV) function, and adverse clinical outcomes. Cardiovascular magnetic resonance (CMR), especially susceptibility-sensitive techniques such as T2* or R2* mapping, enables in vivo detection of hemorrhagic microvascular injury and may refine post-MI risk stratification. Mechanistic and translational studies suggest that erythrocyte degradation and infarct-core iron deposition may contribute to persistent inflammation, maladaptive healing, adverse remodeling, and possibly arrhythmogenic substrate formation. However, most clinical evidence remains observational, and IMH-guided management has not yet been prospectively validated. This narrative review summarizes current evidence on the pathophysiology, imaging diagnosis, prognostic significance, and emerging therapeutic implications of IMH, while highlighting unresolved questions regarding standardized imaging, clinical implementation, and future phenotype-directed therapies.
Related Concept Videos
Hemorrhagic Stroke ll: Pathophysiology
Hemorrhagic Stroke l: Introduction
Myocarditis I: Introduction
Ischemic Stroke ll: Pathophysiology
Ischemic Stroke l: Introduction

